Hep Email Update CDC Reports 6% Decline in U.S. Hepatitis C Cases The decline in hepatitis C cases could be attributed to new screening guidelines and expanded access to timely treatment. FDA Approves Vemlidy for Children With Hepatitis B Tenofovir alafenamide is safe and effective for pediatric patients ages 6 and up. Affordable Care Act Plans Are Being Switched Without Enrollees’ OK Unauthorized enrollment or plan-switching is emerging as a serious challenge for Obamacare participants. Advertisement Weight-Loss Surgery Yields Long-Term Benefits for Type 2 Diabetes Bariatric surgery helped people better control their blood glucose years later compared to medical and lifestyle interventions. What Is Fatty Liver Disease? (MASLD and MASH) Learn the latest about fatty liver. What Is Hepatitis C? Get the basics! Advertisement Science News Weight-Loss Surgery Yields Long-Term Benefits for Type 2 Diabetes FDA Approves Vemlidy for Children With Hepatitis B FDA Authorizes New COVID-19 Prevention for Immunocompromised People Daily Aspirin Reduces Liver Fat in People With MASLD Newsfeed CDC Reports 6% Decline in U.S. Hepatitis C Cases Rapid Vaccine Rollout Prevented a Hepatitis A Outbreak at LA County Jail Cancer Advocates Celebrate Anniversary of the Affordable Care Act UNAIDS Urges Scaling Up of Evidence-Based Services to Address the Transmission of HIV and Viral Hepatitis Among People Who Use Drugs Science News Weight-Loss Surgery Yields Long-Term Benefits for Type 2 Diabetes FDA Approves Vemlidy for Children With Hepatitis B FDA Authorizes New COVID-19 Prevention for Immunocompromised People Daily Aspirin Reduces Liver Fat in People With MASLD Newsfeed CDC Reports 6% Decline in U.S. Hepatitis C Cases Rapid Vaccine Rollout Prevented a Hepatitis A Outbreak at LA County Jail Cancer Advocates Celebrate Anniversary of the Affordable Care Act UNAIDS Urges Scaling Up of Evidence-Based Services to Address the Transmission of HIV and Viral Hepatitis Among People Who Use Drugs

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@hepmag.com. Please remember to add update@hepmag.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: